Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-11-14 Purchase | 2022-11-16 4:58 pm | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 16,053 | $3.0934 | $49,659 | 24,238 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-12-31 Tax Withholding | 2024-01-03 7:39 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 3,098 | $0.3402 | 142,945 (Direct) | View |
2023-12-31 Exercise | 2024-01-03 7:39 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 8,952 | $0 | 142,945 (Direct) | View |
2023-09-30 Exercise | 2023-10-03 7:30 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 8,953 | $0 | 146,043 (Direct) | View |
2023-09-30 Tax Withholding | 2023-10-03 7:30 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 2,624 | $0.6199 | 146,043 (Direct) | View |
2023-06-30 Exercise | 2023-07-03 6:51 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 13,841 | $0 | 148,667 (Direct) | View |
2023-06-30 Tax Withholding | 2023-07-03 6:51 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 4,057 | $0.855 | 148,667 (Direct) | View |
2023-03-31 Exercise | 2023-04-04 5:15 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 4,063 | $0 | 74,490 (Direct) | View |
2023-03-31 Tax Withholding | 2023-04-04 5:15 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 1,154 | $1.39 | 74,490 (Direct) | View |
2023-02-01 Option Award | 2023-02-03 6:44 pm | N/A 2033-02-01 | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 180,922 | $0 | 229,672 (Direct) | View |
2022-12-31 Exercise | 2023-01-03 4:07 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 4,062 | $0 | 75,644 (Direct) | View |
2022-12-31 Tax Withholding | 2023-01-03 4:07 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 1,406 | $2.37 | 75,644 (Direct) | View |
2022-09-30 Exercise | 2022-10-03 7:42 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 4,063 | $0 | 60,997 (Direct) | View |
2022-09-30 Tax Withholding | 2022-10-03 7:42 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 1,191 | $1.52 | 60,997 (Direct) | View |
2022-06-30 Exercise | 2022-07-01 4:17 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 8,125 | $0 | 62,188 (Direct) | View |
2022-06-30 Tax Withholding | 2022-07-01 4:17 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 2,812 | $2.299 | 62,188 (Direct) | View |
2022-02-02 Option Award | 2022-02-04 7:29 pm | N/A 2032-02-01 | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 150,000 | $0 | 150,000 (Direct) | View |
2021-06-30 Option Award | 2021-07-02 5:07 pm | N/A 2031-05-31 | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 30,000 | $0 | 30,000 (Direct) | View |
2021-06-01 Option Award | 2021-06-02 4:11 pm | N/A 2031-05-31 | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 70,000 | $0 | 70,000 (Direct) | View |
Ownership | 2021-06-01 8:04 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 0 | $0 | 70,000 (Direct) | View |